World-Class Leaders to Headline HIMSS25 Global Conference

LAS VEGAS, Nov. 19, 2024 /PRNewswire/ — Informa Markets announced an exceptional lineup of keynote speakers for the 2025 HIMSS Global Health Conference & Exhibition, including cybersecurity expert General Paul Nakasone, Dr. Seung-woo Park, President, and Dr. Meong Hi Son, CMIO of Samsung Medical Center, and more to address critical healthcare challenges.

General Paul Nakasone, former Director of the National Security Agency, will share crucial perspectives on cybersecurity challenges facing healthcare organizations.

Dr. Park and Dr. Son will showcase cutting-edge developments in digital health transformation and precision medicine.

“This diverse speaker lineup reflects our commitment to addressing the most pressing issues in health IT  today – from mental wellness to cybersecurity defense and technological innovation,” said JoAnn Klinedinst, VP of Content & Programming for the conference.

In addition to these speakers, HIMSS25 will offer brand new exhibit hall features, such as the AI Pavilion, Interop+Smart Experience Pavilion, and two new preconference forums focused on smart health transformation and health equity.

HIMSS25 will take place March 3-6, 2025, at the Venetian Convention & Expo Center, Caesars Forum, and Wynn Las Vegas. To register, visit himssconference.com.

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. We provide marketplace participants around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, targeted digital services and actionable data solutions. We connect buyers and sellers across more than a dozen global verticals, including Pharmaceuticals, Food, Medical Technology and Infrastructure. As the world’s leading market-making company, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.

About HIMSS

HIMSS (Healthcare Information and Management Systems Society) is a global advisor, thought leader and member-based society committed to reforming the global health ecosystem through the power of information and technology. As a mission-driven nonprofit, HIMSS offers a unique depth and breadth of expertise in health innovation, public policy, workforce development, research and digital health transformation to advise leaders, stakeholders and influencers across the global health ecosystem on best practices. With a community-centric approach, our innovation engine delivers key insights, education and engaging events to healthcare providers, payers, governments, startups, life sciences and other health services organizations, ensuring they have the right information at the point of decision.

View original content to download multimedia:https://www.prnewswire.com/news-releases/world-class-leaders-to-headline-himss25-global-conference-302309704.html

SOURCE Informa Markets

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

44 minutes ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

45 minutes ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

48 minutes ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

49 minutes ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

49 minutes ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…

49 minutes ago